1. Background {#sec0005}
=============

WU polyomavirus (WUPyV) is a relatively new human polyomavirus first detected in respiratory samples in 2007 \[[@bib0005]\]. It has since then been detected in respiratory tract samples in both immunocompetent and immunocompromised patients worldwide \[[@bib0010], [@bib0015], [@bib0020], [@bib0025], [@bib0030], [@bib0035]\]. However, its pathogenic role remains unclear, especially in pediatric patients with severe respiratory failure.

We had previously performed metagenomic shotgun sequencing for comprehensive detection of pathogens in selected patients without an etiological diagnosis and detected genomic fragments of WUPyV from a patient with respiratory failure. We therefore decided to undertake a retrospective study of WUPyV infection.

2. Objectives {#sec0010}
=============

The aim of this study was to evaluate the characteristics of severe respiratory failure associated with WUPyV in children.

3. Study design {#sec0015}
===============

3.1. Study population {#sec0020}
---------------------

This retrospective study was conducted at the National Center for Child Health and Development, a pediatric tertiary care hospital in Tokyo, Japan. We identified pediatric patients (\<18 years) with respiratory failure whose respiratory tract specimens were evaluated by PCR for respiratory pathogens between April 2010 and April 2017. Residual nucleic acid specimens were evaluated by real-time PCR for WUPyV according to established methods \[[@bib0040],[@bib0045]\]. For patients whose specimen was positive for WUPyV, we extracted clinical information including age, sex, underlying disease, clinical course, and prognosis from the patients' medical records.

3.2. Co-detection of other pathogens {#sec0025}
------------------------------------

Co-detection of other pathogens was evaluated in two steps. First, sputum culture and other nucleic acid testing performed as part of the clinical workup at the time of the episode of respiratory failure was reviewed. Coagulase negative *Staphylococcus* species and *Neisseria* species were considered not clinically significant and excluded. Second, multiplex real-time PCR using the Fast-track Diagnostics Respiratory Pathogens 21 (FTDRP21) multiplex assay kit (Fast-track Diagnostics, Luxembourg) was performed using the same residual samples that were used for WUPyV detection. The panel was able to detect 21 respiratory pathogens simultaneously including: influenza A, influenza A (H1N1) pdm09, influenza B, rhinovirus, coronavirus NL63, 229E, OC43, and HKU1, parainfluenza 1, 2, 3, and 4, human metapneumovirus A/B, bocavirus, respiratory syncytial virus A/B, adenovirus, enterovirus, parechovirus, *Mycoplasma pneumoniae*, and an internal control \[[@bib0050]\].

4. Results {#sec0030}
==========

Three hundred eighteen samples were subjected to real-time PCR analysis. Among these, 14 (4.4%) samples were positive for WUPyV. The demographic and clinical characteristics are summarized in [Table 1](#tbl0005){ref-type="table"} . The majority of the respiratory samples (n = 11, 79%) were taken from the lower respiratory tract. An underlying disease was found in 11 (79%) patients, including five preterm children and three immunocompromised patients. The details of the patients are shown in [Table 2](#tbl0010){ref-type="table"} . The sequences of WUPyV had been identified from sputum specimens by metagenomic analysis from one immunocompromised child with respiratory failure ([Table 2](#tbl0010){ref-type="table"}, Patient 3, Supplementary Data 1). The patients were classified into four groups based on their underlying conditions: immunocompromised (Group 1), preterm (Group 2), other underlying diseases (Group 3) or previously healthy patients (Group 4). All cases with prematurity (Patients 4, 5, 6, 7, 8) and other underlying disorders (Patients 9, 10, 11) had a history of admission to the neonatal intensive care unit (NICU). Other viruses were co-detected in nine patients while only WUPyV was detected in five patients (Patients 5, 7, 9, 10, 11). Sputum cultures were evaluated in 11 patients, but clinically significant bacterial pathogens were not detected. All five patients in whom only WUPyV was detected had a history of admission to the NICU and presented with fever, cough, and respiratory distress and were intubated within one to six days after the onset of symptoms. The chest X-rays of the five patients are shown in [Fig. 1](#fig0005){ref-type="fig"} . Typical findings were apparent perihilar bilateral infiltration compatible with viral pneumonia.Table 1The demographic, clinical data, and outcomes of patients with WU polyomavirus.Table 1Cases%N = 14Age (months); median (range)34 (8-105)Sex: male1071%Underlying disease1179% Immunosuppressive status321% Preterm536% Other underlying diseases321%  Clinical diagnosis Pneumonia1393% Bronchiolitis17%  Respiratory Samples Endotracheal tube aspirates964% Sputum214% Nasopharyngeal swab321%Detection of other pathogens964%Mechanical Ventilation964%Extracorporeal membrane oxygenation214%Death214%Table 2Demographic and clinical details and outcomes of 14 patients with WU polyomavirus.Table 2PtGroupAge (month)SexUnderlying DiseaseDiagnosisIntubationECMOSamplesCo-detected organismsOutcome1132MalePost liver transplant for fulminant hepatitisPneumonia----UpperRhinovirusAlive2136MalePost liver transplant for fulminant hepatitisPneumonia+--LowerRhinovirusAlive3151MaleActivated PI3 Kinase delta syndromePneumonia++LowerKI polyomavirus[\*](#tblfn0005){ref-type="table-fn"}Dead426MalePreterm (30 w, 1560 g)Bronchiolitis----UpperHuman coronavirus NL63, Human MetapneumovirusAlive528FemalePreterm (28 w, 683 g), 21 trisomyPneumonia+--LowerNegativeAlive6219FemalePreterm (22 w, 335 g), chronic lung diseasePneumonia----UpperAdenovirusAlive7223MalePreterm (26 w, 900 g)Pneumonia+--LowerNegativeAlive8241FemalePreterm (26 w, 435 g), chromosomal abnormalityPneumonia+--LowerRespiratory syncytial virusDead9312MaleKlinefelter syndrome (41 w, 2666 g)Pneumonia+--LowerNegativeAlive10354MaleMyelomeningocele (37 w, 1994 g)Pneumonia+--LowerNegativeAlive113105MaleNeonatal hypoxic-ischemic encephalopathy (41 w, 4046 g)Pneumonia+--LowerNegativeAlive12415Female--Pneumonia++LowerHuman MetapneumovirusAlive13442Male--Pneumonia----LowerParainfluenza type 2, Adenovirus, EnterovirusAlive14479Male--Pneumonia----Lower*Mycoplasma pneumoniae*Alive[^1][^2]Fig. 1Radiograph findings of five patients with single detection of WU polyomavirus.Radiograph (A)--(E), correspond to Patients 5, 7, 9, 10, 11, respectively. Apparent bilateral infiltration was seen in (A), (B), and (D); infiltration of the right hilar area was seen in (C); and infiltration of the right middle lung area and left lower lung area was seen in (E).Fig. 1

Regarding the severity and prognosis, two patients (Patients 3 and 12) required extracorporeal membrane oxygenation (ECMO) and two patients (Patients 3 and 8) died. Although the respiratory condition of Patient 3 gradually improved, and ECMO was discontinued, multi-organ failure progressed and ultimately proved fatal. Patient 8, who had a chromosomal abnormality, died of respiratory failure and multi-organ failure.

5. Discussion {#sec0035}
=============

WUPyV was detected in 14 of 318 (4.4%) lower respiratory samples of children with severe respiratory failure. In five patients, WUPyV was the only detected pathogen despite the extended microbiological evaluation including bacterial cultures and multiplex real-time PCR.

The pathogenic role of WUPyV is still debated. Several reports revealed a similar detection rate from respiratory samples in children with or without respiratory symptoms \[[@bib0010],[@bib0020],[@bib0025]\]. In most previous reports, the samples were taken by nasopharyngeal swab, and the majority of the cases had no underlying condition. In our case series, the majority of WUPyV were detected from lower respiratory specimens, suggesting that WUPyV may cause lower respiratory infection.

In the current study, the majority of the patients had an underlying condition. Immunocompromised status was observed in three patients. WUPyV infections have been reported previously in immunocompromised patients. Siebrasse EA et al. reported an adult lung transplant recipient with Job syndrome and a pediatric bone marrow transplant recipient with fatal acute respiratory failure. In these cases, the WUPyV viral protein was detected by immunohistochemical staining of tissue from the respiratory tract, including lung tissue, which indicated the possibility of a pathogenic role for WUPyV in immunocompromised patients \[[@bib0055],[@bib0060]\].

Apart from immunocompromised status, eight patients had a history of admission to the NICU. Of these patients, five were preterm patients. To our knowledge, no report has documented the association of prematurity or history of NICU admission with WUPyV infection. It is well known that prematurity is a risk factor for a number of respiratory virus infections, such as respiratory syncytial virus. Immature cell-mediated immunity and lung function (functional residual capacity, compliance, and resistance of the respiratory system) are thought to contribute to the pathogenesis \[[@bib0065],[@bib0070]\]. A similar pathogenesis may also be at work in the lower respiratory tract of premature children with a WUPyV infection.

Other viruses were co-detected in nine of 14 (64%) patients. These viruses included respiratory syncytial virus, rhinovirus, coronavirus, human metapneumovirus, parainfluenza virus, adenovirus, enterovirus, KI polyomavirus, and *Mycoplasma pneumoniae.* Codetection of WUPyV with other respiratory viruses has often been reported in children and was consistent with the findings of our study \[[@bib0010],[@bib0020],[@bib0025]\]. It is still unknown if codetection of WUPyV with other viruses was associated with the severity of respiratory failure.

A major limitation of this study is the lack of histological evidence of WUPyV infection. The pathogenic role of WUPyV in respiratory failure remains unclear. Nonetheless, WUPyV alone was detected from the lower respiratory samples of several children with respiratory failure, and our findings add new insights into the clinical importance of WUPyV in children.

In conclusion, WUPyV was detected in children with severe respiratory failure. It can be pathogenic independently or concomitantly with other pathogens, especially in patients with a history of preterm birth or an underlying disease.
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[^1]: Abbreviation: ECMO: Extra corporeal membrane oxygenation.

[^2]: Detected by metagenomic analysis.
